文章基本信息

标题：Immunity to SARS-CoV-2 up to 15 months after infection
本地全文：下载
作者：Harold Marcotte ; Antonio Piralla ; Fanglei Zuo 等
期刊名称：iScience
印刷版ISSN：2589-0042
出版年度：2022
卷号：25
期号：2
页码：1-20
DOI：10.1016/j.isci.2022.103743
语种：English
出版社：Elsevier
摘要：SummaryInformation concerning the longevity of immunity to SARS-CoV-2 following natural infection may have considerable implications for durability of immunity induced by vaccines. Here, we monitored the SARS-CoV-2 specific immune response in COVID-19 patients followed up to 15 months after symptoms onset. Following a peak at day 15–28 postinfection, the IgG antibody response and plasma neutralizing titers gradually decreased over time but stabilized after 6 months. Compared to G614, plasma neutralizing titers were more than 8-fold lower against variants Beta, Gamma, and Delta. SARS-CoV-2-specific memory B and T cells persisted in the majority of patients up to 15 months although a significant decrease in specific T cells, but not B cells, was observed between 6 and 15 months. Antiviral specific immunity, especially memory B cells in COVID-19 convalescent patients, is long-lasting, but some variants of concern may at least partially escape the neutralizing activity of plasma antibodies.Graphical abstractDisplay OmittedHighlights•Plasma neutralizing antibodies persist in the majority of patients up to 15 months•Neutralizing activity is lower against variants of concern Delta, Beta, and Gamma•Specific memory B and T cells were present in 95% of patients up to 15 months•Specific T cells, but not B cells, were decreased between 6 and 15 monthsImmunology; Immune response; Virology